2007
DOI: 10.1038/sj.gt.3302977
|View full text |Cite
|
Sign up to set email alerts
|

Progress and prospects: RNA-based therapies for treatment of HIV infection

Abstract: The current treatment regimen for HIV-infected individuals combines two or more drugs targeting different viral proteins such as RT and gag. Resistance to conventional drugs can develop quickly, and typically persists. The prospect of longer, continuous antiretroviral therapy brings with it the need for new antiretroviral drugs and approaches. In this context, gene therapies have the potential to prolong life and quality of life as an additional therapeutic class and may serve as an adjuvant to traditional tre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
51
0
1

Year Published

2009
2009
2015
2015

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(52 citation statements)
references
References 66 publications
0
51
0
1
Order By: Relevance
“…Several molecules targeting the HIV RNA have been used to decrease HIV replication in cell culture, 12,36,37 in animal models 38 and some of them are in clinical trials for their use in gene therapy. 13,14,39 The experience with these compounds has provided several orientations and possible improvements including: (1) New compounds are always needed as leads 4 GApDh copies and normalized to a value of 100% for the hDV-Rzctl.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several molecules targeting the HIV RNA have been used to decrease HIV replication in cell culture, 12,36,37 in animal models 38 and some of them are in clinical trials for their use in gene therapy. 13,14,39 The experience with these compounds has provided several orientations and possible improvements including: (1) New compounds are always needed as leads 4 GApDh copies and normalized to a value of 100% for the hDV-Rzctl.…”
Section: Discussionmentioning
confidence: 99%
“…14,15,39,40 siRNAs have received much attention during the last years and their use against infectious agents is widely studied both in cell culture and in vivo using various methods. 41 These studies and numerous possible improvements are promising, but their use in patients will likely require their use in combination therapy to avoid viral escape.…”
Section: ©2 0 1 1 L a N D E S B I O S C I E N C E D O N O T D I S Tmentioning
confidence: 99%
“…Vast amount of resources are being spent by governments to develop new drugs and therapies for the treatment of infected individuals with distinct results (e.g., Scherer et al 2007). However, although several antiviral drugs have proved to successfully reduce the advance of the virus in the organism, they have also caused a series of undesired side effects.…”
mentioning
confidence: 99%
“…Even one base pair change dramatically lowers the potency of RNAimediated inhibition. (58)This becomes important, given the high error rate of HIV-1 reverse transcriptase that leads to the emergence of RNAi escape mutants. The HIV-1 virus often becomes resistant to RNAi therapy as a result of the appearance of mutant variants.…”
Section: Targeting Hiv-1 With Rnaimentioning
confidence: 99%